These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35645232)
1. Drug-Induced vs. Viral Maculopapular Exanthem-Resolving the Dilemma. Khandpur S; Ahuja R Dermatopathology (Basel); 2022 May; 9(2):164-171. PubMed ID: 35645232 [TBL] [Abstract][Full Text] [Related]
2. Assessment of histopathological features of maculopapular viral exanthem and drug-induced exanthem. Singh S; Khandpur S; Arava S; Rath R; Ramam M; Singh M; Sharma VK; Kabra SK J Cutan Pathol; 2017 Dec; 44(12):1038-1048. PubMed ID: 28914958 [TBL] [Abstract][Full Text] [Related]
3. Histopathologic Features of Maculopapular Drug Eruption. Ernst M; Giubellino A Dermatopathology (Basel); 2022 Mar; 9(2):111-121. PubMed ID: 35466243 [TBL] [Abstract][Full Text] [Related]
4. Histopathological Characterization of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) and Comparison with Maculopapular Drug Rash (MPDR). Jindal R; Chugh R; Chauhan P; Shirazi N; Bisht YS Indian Dermatol Online J; 2022; 13(1):32-39. PubMed ID: 35198465 [TBL] [Abstract][Full Text] [Related]
6. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression. Weinborn M; Barbaud A; Truchetet F; Beurey P; Germain L; Cribier B Int J Dermatol; 2016 Nov; 55(11):1225-1233. PubMed ID: 27421110 [TBL] [Abstract][Full Text] [Related]
7. Histopathologic features of exanthematous drug eruptions of the macular and papular type. Naim M; Weyers W; Metze D Am J Dermatopathol; 2011 Oct; 33(7):695-704. PubMed ID: 21785331 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. Yawalkar N; Shrikhande M; Hari Y; Nievergelt H; Braathen LR; Pichler WJ J Allergy Clin Immunol; 2000 Dec; 106(6):1171-6. PubMed ID: 11112902 [TBL] [Abstract][Full Text] [Related]
10. The mixed spongiotic and interface reaction pattern: A study of clinical and histopathologic findings. Ernst M; Lundgren M; Evans MD; Miller D; Giubellino A J Cutan Pathol; 2022 Dec; 49(12):1051-1059. PubMed ID: 36445270 [TBL] [Abstract][Full Text] [Related]
15. The immunological and clinical spectrum of delayed drug-induced exanthems. Lerch M; Pichler WJ Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):411-9. PubMed ID: 15349041 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the cutaneous exanthem in macaques infected with a Nef gene variant of SIVmac239. Sasseville VG; Rottman JB; Du Z; Veazey R; Knight HL; Caunt D; Desrosiers RC; Lackner AA J Invest Dermatol; 1998 Jun; 110(6):894-901. PubMed ID: 9620296 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of histopathologic findings in cutaneous eruptions associated with influenza A (H1N1) infection. Kaley J; Pellowski DM; Cheung WL; Hiatt KM J Cutan Pathol; 2013 Feb; 40(2):226-9. PubMed ID: 23216248 [TBL] [Abstract][Full Text] [Related]
18. Histologic findings in acute HIV exanthem. Goldman GD; Milstone LM; Shapiro PE J Cutan Pathol; 1995 Aug; 22(4):371-3. PubMed ID: 7499579 [TBL] [Abstract][Full Text] [Related]
19. Gloves and socks syndrome: early and late histopathologic features. Smith SB; Libow LF; Elston DM; Bernert RA; Warschaw KE J Am Acad Dermatol; 2002 Nov; 47(5):749-54. PubMed ID: 12399769 [TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular pathophysiology of cutaneous drug reactions. Pichler WJ; Yawalkar N; Britschgi M; Depta J; Strasser I; Schmid S; Kuechler P; Naisbitt D Am J Clin Dermatol; 2002; 3(4):229-38. PubMed ID: 12010068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]